Archive for the ‘Access’ Category
Confessions of a European health consumer
In: Access| Awareness| Online community| Patient-focus| Regulations
9 oct 2009Today, I was looking for information for my Dad who is a type 2 diabetic. I was interested to see, if a certain type of insulin could control his diabetes better. Naturally, I went online and typed the product in question into Google. The site that came up was the American product site. There [...]
GSK France and the future of the healthcare system
In: Access| government
2 mar 2009Voilà a very clever initiative from GSK France illustrating how pharma can use its priviledged position at the cross-roads of many important influencers to drive positive change of the healthcare system.
In 2005, GSK France under their CEO Hervé Gisserot started a blog to facilitate the discussion between French citizens and the main stakeholders of the [...]
Check out this great initiative, patientassistance.com, which provides a sort of one-stop shop for uninsured patients to find out and enlist in pharmaceutically sponsored patient assistance programs.
This is a wonderful example of how non-profit, patient communities and pharma can collaborate to improve access to treatments. If you are working for a pharma company, please check [...]
- No Comments
- Tags: Access, patient, pharma, treatment
About this blog
The Internet holds the power to profoundly change the way healthcare is delivered. Millions of patients, caregivers and physicians turn to the Internet every day to look up the latest information on important health topics and find support from like-minded people.
Categories
- #hcsmeu (11)
- Access (8)
- Adherence (3)
- Adverse Events (1)
- Awareness (6)
- EU policy (3)
- Events (3)
- government (5)
- Guidance (5)
- Non classé (2)
- Online community (11)
- Patient-focus (16)
- Regulations (6)
- Social media tools (23)
- strategy (15)
- twitter (13)
- Matt Owen: Despite increasing adoption, there's still a tendency by many businesses (not just Pharma) to funnel [...]
- Dana Webster: I've only been able to loosely follow the conversation and to glance at the entire Roche document. [...]
- Andrew Spong: Hi Silja It was a great idea of yours to collate these opinions into a video, and thank you for a [...]
- Does it matter that Roche published its social media guidance? - whydot pharma: [...] Non classé 23 août 2010 As promised here, please find now below the first video on the R [...]
- The white elephant in the room: the FDA hearing and DTC | Treat My Brand | Haider Alleg: [...] DTC TV ads and despise the idea of it leaking into their social media haven. And I have to agr [...]
- Roche guidance won’t impact us…but it might impact our convo
- Does Roche need to separate social media guidance into personal and professional?
- Is the Roche social media guidance clear?
- Does it matter that Roche published its social media guidance?
- Opinion poll on Roche social media guidance
- E-patients’ moments-of-truth are social
- Pharma social media? Or pharma engagement in social media?
- Fake Sara ticks me off. Get real Medseek!
- How to run an unconference: an introduction to #hcsmeucamp
- Pharma twittersphere- who is following you- Part III